Medicine and Dentistry
Disease
100%
Hepatocellular Carcinoma
71%
Chronic Obstructive Pulmonary Disease
70%
Prevalence
67%
Abdominal Cancer
65%
Neoplasm
64%
Atrial Fibrillation
61%
Odds Ratio
60%
Overall Survival
60%
Hazard Ratio
59%
Diagnosis
58%
Computer Assisted Tomography
54%
Malignant Neoplasm
53%
Cohort Analysis
51%
Lung
50%
Prognostic Factor
46%
Recurrent Disease
44%
Colonoscopy
42%
Colorectal Carcinoma
40%
Surgery
38%
Adverse Event
34%
Capsule Endoscopy
33%
Infection
33%
Asthma
32%
Clinical Feature
32%
Progression Free Survival
31%
Body Mass Index
30%
Multivariate Analysis
28%
Cardiovascular Disease
27%
Ulcerative Colitis
27%
Uric Acid
27%
Chronic Kidney Disease
27%
Metastatic Carcinoma
27%
Inflammatory Bowel Disease
26%
Metabolic Syndrome
26%
Adenoma
26%
Gastroesophageal Reflux
25%
Lung Tuberculosis
25%
Drug Therapy
24%
Lung Cancer
24%
Non Small Cell Lung Cancer
24%
Survival Rate
24%
Nephropathy
22%
Multiple Myeloma
22%
Rheumatoid Arthritis
22%
Inflammatory Arthritis
22%
Apoplexy
22%
Cardiovascular System
21%
Diabetes
20%
Diabetes Mellitus
20%
Polycystic Ovary Syndrome
20%
Observational Study
20%
Crohn's Disease
20%
Forced Expiratory Volume
20%
Hemodialysis
20%
Blood Pressure
20%
Retrospective Study
19%
Helicobacter Pylori
19%
Stomach Acid
19%
Fibrosis
19%
Endoscopy
19%
Prospective Study
18%
Enteropathy
17%
Combination Therapy
17%
Biopsy Technique
17%
Ablation
17%
Bleeding
17%
Elderly Patient
17%
Pylorus
17%
Polyp
17%
Persistent Atrial Fibrillation
16%
Reflux Esophagitis
16%
Chronic Hepatitis B
16%
Lymph Node Metastasis
16%
Vasculotropin
16%
Meta-Analysis
16%
Chemoradiotherapy
16%
Kidney Function
16%
Cross Sectional Study
15%
Breast Cancer
15%
Idiopathic Pulmonary Fibrosis
15%
Health Care Cost
15%
Placebo
15%
Coronary Artery Disease
15%
Patient with Inflammatory Bowel Disease
15%
Hyperuricemia
15%
Primary Tumor
15%
Endothelial Cell
15%
Pancreas Cancer
15%
Diffuse Large B-Cell Lymphoma
14%
Comorbidity
14%
Mesenchymal Stem Cell
14%
Peritoneal Dialysis
14%
Prospective Cohort Study
14%
Colon
14%
Fluorodeoxyglucose F 18
14%
Predictive Factor
14%
End Stage Renal Disease
14%
Endoscopic Surgery
14%
Retrospective Cohort Study
14%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
86%
Liver Cell Carcinoma
68%
Prevalence
63%
Malignant Neoplasm
62%
Overall Survival
61%
Chronic Obstructive Lung Disease
57%
Asthma
56%
Adverse Event
55%
Uric Acid
51%
Abdominal Cancer
47%
Neoplasm
45%
Cohort Study
43%
Infection
40%
Atrial Fibrillation
35%
Recurrent Disease
34%
Progression Free Survival
33%
Chronic Kidney Failure
30%
Clinical Feature
30%
Diabetes Mellitus
29%
Placebo
27%
Cardiovascular Disease
26%
Hemodialysis
26%
Chronic Hepatitis B
25%
Inflammatory Bowel Disease
24%
Multiple Myeloma
23%
Non Small Cell Lung Cancer
23%
Colorectal Carcinoma
23%
Survival Rate
23%
Inflammatory Arthritis
22%
Rheumatoid Arthritis
22%
Helicobacter Pylori
22%
Combination Therapy
22%
Ulcerative Colitis
21%
Monotherapy
20%
Lung Cancer
20%
Crohn's Disease
20%
Prospective Study
19%
Hyperuricemia
19%
Kidney Disease
18%
Cisplatin
18%
Acetylsalicylic Acid
18%
Lung Tuberculosis
17%
Fibrosis
17%
Remission
17%
Coughing
17%
Non Insulin Dependent Diabetes Mellitus
17%
Metabolic Syndrome X
17%
Hepatitis B Virus
16%
Bleeding
16%
Cerebrovascular Accident
16%
Observational Study
16%
Endothelial Dysfunction
15%
End Stage Renal Disease
15%
Chronic Cough
15%
Sorafenib
15%
Breast Cancer
15%
Hepatitis B
14%
Stomach Acid
14%
Bloodstream Infection
14%
Inflammation
14%
Gemcitabine
13%
Comorbidity
13%
Biological Marker
13%
Retrospective Study
13%
Coronary Artery Disease
13%
Prospective Cohort Study
13%
Anticoagulant Agent
13%
Tumor Necrosis Factor
13%
Pancreas Cancer
13%
Antibiotics
13%
Adenoma
12%
Paclitaxel
12%
Cytokine
12%
C Reactive Protein
12%
Capecitabine
12%
Disease Activity
12%
All Cause Mortality
11%
Clinical Study
11%
Syndrome
11%
Fluorouracil
11%
Liver Cirrhosis
11%
Messenger RNA
11%
Oxaliplatin
11%
Imatinib
11%
Antiinfective Agent
11%
Docetaxel
11%
Metastatic Colorectal Cancer
11%
Antivirus Agent
11%
Mortality Rate
11%
Fibrosing Alveolitis
11%
Nitric Oxide
10%
Gastrointestinal Hemorrhage
10%
Insulin Resistance
10%
Staphylococcus Aureus
10%
Dexamethasone
10%
Heart Infarction
10%
Phase II Trials
10%
Bronchodilating Agent
10%
Disease Exacerbation
9%
Epidermal Growth Factor Receptor
9%